Golden Week Box Office Slump: 8-Day Holiday Sees 278 Million Yuan Drop

Blockbusters That Didn’t Boom, Dark Horses That Didn’t Break Through — China’s Golden Week Box Office Cools Sharply

This year’s National Day “Golden Week” box office was noticeably colder than last year’s. Across the eight-day holiday, total revenue reached 1.827 billion yuan, a drop of 278 million yuan compared to last year’s seven-day total of 2.105 billion yuan, falling back to levels not seen in nearly a decade. The much-anticipated blockbusters failed to ignite, and the would-be dark horses never broke through. From the outset, a weaker content lineup hinted at this outcome. Yet amid the chill lies one certainty: the enduring pull of patriotic, “main-melody” storytelling. The path forward will depend on richer diversity and higher-quality production.

Following a strong summer season that earned 11.9 billion yuan, optimism for the National Day window was high. The slate looked promising, with a mix of major productions. But the results disappointed. As of 8 p.m. on October 8, total takings stood at 1.827 billion yuan, down 13.2% year-on-year and plunging back to 2015 levels. Average ticket prices dropped to 36.6 yuan, down 3.7 yuan from last year, lowering the entry barrier for audiences. Even so, attendance fell: 50 million tickets sold this year versus 52.23 million last year, a decline of 2.23 million viewers. The holiday’s once-magnetic draw clearly weakened.

The problem lies on the supply side: despite many releases, there were no true hits to drive the market. Mid-tier titles underperformed across the board. “The Volunteers: Blood and Peace,” the finale to the “Volunteers” trilogy, was expected to dominate but managed only 450 million yuan, nearly halving the previous film’s total. “Assassin in Red 2,” a sequel to the 1 billion yuan original, barely passed 300 million yuan, failing to sustain the brand’s momentum. More strikingly, the second-highest-grossing film of the period was “731,” a title already in release for over 20 days, earning 340 million yuan during the holiday—highlighting the lack of fresh, competitive titles. Smaller, critically praised films such as “Deafening” (7.5 on Douban), “Proof of Bi Zhengming” (7.4), and “The Starry Sky of the Three Kingdoms” (7.2) won acclaim but not audiences. Only “Deafening” surpassed 170 million yuan, while the others failed to cross the 100 million mark.

As China’s fourth-largest moviegoing season, the National Day slot is crucial for film-studio earnings. So who thrived, who stumbled, and who simply survived? China Film Co. (600977.SH) entered the holiday with the widest portfolio—backing “The Volunteers: Blood and Peace,” “Assassin in Red 2,” “Deafening,” and “The Stray Life.” Yet its flagship title is projected to gross 602 million yuan in total, with a revenue share around 220 million yuan—insufficient for profit. Fortunately, its summer blockbuster “Nanjing Photo Studio” provided earlier gains to offset risks. Bona Film Group (001330.SZ), still reeling from a 1.056 billion yuan first-half loss after “Operation Flood Dragon” underperformed, saw little relief—its sole participation this season was “The Volunteers: Blood and Peace.” Huace Film & TV and Maoyan Entertainment, co-producers of “Assassin in Red 2,” face unavoidable losses if the rumored 300 million yuan budget is accurate. Shanghai Tingdong Pictures and Maoyan, behind “The Stray Life,” are in similar straits: projected 328 million yuan gross against a 200 million yuan cost spells likely red ink. Even Enlight Media, the secondary producer of “The Starry Sky of the Three Kingdoms Part I,” risks losses, with only 96 million yuan expected. By contrast, Lianrui Pictures’ modestly budgeted “Deafening,” focused on realistic life-and-death themes, stands out. With an estimated 227 million yuan gross, it may emerge as the holiday’s only profitable film. Behind these numbers lies a familiar dynamic: producers of big-IP or star-director projects often hedge early by selling shares at a premium, securing returns before release. This upstream risk-transfer practice squeezes downstream partners’ potential profit even further.

As patriotic dramas lose their automatic draw, both filmmakers and audiences are asking: does the “main-melody” genre still belong to the National Day slot? The answer: the genre itself isn’t fading—uninspired storytelling is. Early Golden Weeks were ruled by crowd-pleasing comedies like “Goodbye Mr. Loser.” In 2016, “Operation Mekong” ignited the patriotic wave, turning the genre into a regular box-office champion. But oversaturation bred predictability. Many recent titles rely on formulaic plots, flat characters, and forced sentiment, leading to what critics call “tribute fatigue.” “The Volunteers: Blood and Peace” epitomizes this issue. With cookie-cutter characters and patchwork storytelling, its “pre-packaged creativity” feels misaligned with today’s content-driven market, resulting in poor returns.

However, signs of renewal are visible. Last year’s lineup included just one standard patriotic film; most others were diverse commercial titles. This year, offerings like “Assassin in Red 2” and “The Stray Life” expanded genres further, reducing overreliance on state-themed narratives. Still, the strongest performers remain those with authentic patriotic depth. Both last year’s and this year’s top-grossing films came from this category. “731,” for instance, led with an impressive 17.8 viewers per screening, underscoring sustained audience appetite for well-crafted national stories. Meanwhile, “Nanjing Photo Studio”—hailed as the “savior” of the summer box office—proved that audiences reward originality and sincerity over formula. Its emotional precision and historical insight propelled it past 3 billion yuan in revenue.

In short, the patriotic genre remains powerful, but its vitality depends on reinvention. Filmmakers must explore deeper human narratives, polish cinematic quality, and replace shortcuts with genuine craft. Only then can China’s National Day box office reignite—and truly honor the spirit of the silver screen.